Q4 2019 Navidea Biopharmaceuticals Inc Earnings Call Transcript
Greetings. Welcome to Navidea Biopharmaceuticals Q4 2019 Earnings and Business Update Conference Call. (Operator Instructions) Please note, this conference is being recorded.
I would now like to turn the conference over to your host, Mr. Jed Latkin, CEO. Thank you. You may begin.
Thank you. Good afternoon, and welcome, everyone, to Navidea's Fourth Quarter 2019 Earnings Call. I am Jed Latkin, Chief Executive Officer of Navidea Biopharmaceuticals. This call will cover Navidea's financial and operating results for the fourth quarter of 2019, which ended on December 31, 2019, along with a discussion of goals and milestones for 2020.
Following our prepared remarks, we will open up the conference call to a question-and-answer session. With me on our call today is our Chief Medical Officer, Dr. Mike Rosol; and our Director of Finance and Administration, Erika Eves.
But before we begin our formal remarks, I would like to remind everyone that some of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |